These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20510168)

  • 1. [A new view of psoriasis].
    Jullien D; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):3-7. PubMed ID: 20510168
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis--recent advances in understanding its pathogenesis and treatment.
    Krueger G; Ellis CN
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S94-100. PubMed ID: 15968269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
    Cassano N; Coviello C; Loconsole F; Miracapillo A; Vena GA
    Eur J Dermatol; 2006; 16(3):316-7. PubMed ID: 16709508
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoriasis: from pathogenesis to novel therapeutic approaches.
    Monteleone G; Pallone F; MacDonald TT; Chimenti S; Costanzo A
    Clin Sci (Lond); 2011 Jan; 120(1):1-11. PubMed ID: 20846119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver disease and psoriasis].
    Rivera R; Vanaclocha F
    Actas Dermosifiliogr; 2010 Oct; 101(8):657-8. PubMed ID: 20965008
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis and the metabolic syndrome.
    Gottlieb AB; Dann F; Menter A
    J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concepts for immune intervention in psoriasis vulgaris].
    Nestle FO
    Praxis (Bern 1994); 2000 Sep; 89(37):1468-70. PubMed ID: 11037618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
    Sobell JM; Kalb RE; Weinberg JM
    J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the immune system and immunological circuits in psoriasis.
    Jabbari A; Johnson-Huang LM; Krueger JG
    G Ital Dermatol Venereol; 2011 Feb; 146(1):17-30. PubMed ID: 21317854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation in psoriasis and obesity: implications for therapy.
    Hamminga EA; van der Lely AJ; Neumann HA; Thio HB
    Med Hypotheses; 2006; 67(4):768-73. PubMed ID: 16781085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenesis and role of T cells in psoriasis.
    Ghoreschi K; Weigert C; Röcken M
    Clin Dermatol; 2007; 25(6):574-80. PubMed ID: 18021895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis in patients with psoriasis.
    Gulliver W
    Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three decades of psoriasis research: where has it led us?
    Sabat R; Sterry W; Philipp S; Wolk K
    Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: dysregulation of innate immunity.
    Bos JD; de Rie MA; Teunissen MB; Piskin G
    Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.